An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

Ghislaine A. van Mastrigt*, Silvia M. Evers, Marco Heerings, Leo H. Visser, Rob P. Ruimschotel, Astrid Hussaarts, Lotte Duyverman, Joyce Valkenburg-Vissers, Job Cornelissen, Michel Bos, Maarten van Droffelaar, Peter J. Jongen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number0236-RT.R1/1609300
Pages (from-to)967-980
Number of pages14
JournalJournal of Medical Economics
Volume22
Issue number10
DOIs
Publication statusPublished - 3 Oct 2019

Keywords

  • Relapsing remitting
  • multiple sclerosis
  • trial-based
  • economic evaluation
  • intense social cognitive theory-based treatment
  • self-efficacy
  • multidisciplinary
  • QUALITY-OF-LIFE
  • PREFERENCE-BASED MEASURE
  • SELF-EFFICACY
  • COST-EFFECTIVENESS
  • PHYSICAL-ACTIVITY
  • BEHAVIORAL THERAPY
  • UTILITY MEASURES
  • ADJUSTMENT GROUP
  • CLINICAL-TRIAL
  • HEALTH

Cite this